{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:25:20Z","timestamp":1795109120372,"version":"4.10.3"},"reference-count":81,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Allogeneic hematopoietic stem cell transplantation (allo-HSCT) represents a curative therapy for hematological malignancies, with T-cell immune reconstitution playing a pivotal role in determining clinical outcomes. This review comprehensively illustrates the processes and influencing factors of T-cell recovery post-HSCT, highlighting the dual pathways of reconstitution: thymus-independent peripheral expansion and thymus-dependent central regeneration. Key factors such as recipient and donor age, human leukocyte antigen disparity, conditioning regimens, immunosuppressive therapies, cytomegalovirus reactivation, and graft-versus-host disease (GVHD) significantly impact T-cell reconstitution dynamics and functional recovery. Furthermore, the article discusses the critical balance between graft-versus-leukemia (GVL) effects and GVHD, emphasizing how T-cell exhaustion, inhibitory receptor overexpression, and clonal dynamics contribute to relapse. Emerging technologies, including single-cell multi-omics, spatially resolved proteomics, T cell receptor repertoire analysis, and artificial intelligence-driven modeling, are explored for their potential to deepen mechanistic understanding and enable personalized therapeutic strategies. Ultimately, enhancing T-cell reconstitution through optimized transplantation protocols and targeted interventions is essential for reducing complications and improving long-term survival.<\/jats:p>","DOI":"10.1097\/bs9.0000000000000261","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T21:00:09Z","timestamp":1764622809000},"page":"e00261","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["T Cell immune reconstitution after allo-HSCT: key factors and implications"],"prefix":"10.1097","volume":"7","author":[{"given":"Weiqian","family":"Dai","sequence":"first","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Dong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Cheng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"},{"name":"Tianjin Institutes of Health Science, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Hao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"},{"name":"Tianjin Institutes of Health Science, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"issue":"25","key":"R1-20251201","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1182\/blood-2011-02-334623","article-title":"Thymic T-cell development in allogeneic stem cell transplantation.","volume":"117","author":"Krenger","year":"2011","journal-title":"Blood"},{"issue":"2","key":"R2-20251201","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bbmt.2019.10.026","article-title":"Quantitative analysis of thymus-independent donor-derived T cell expansion in transplant patients.","volume":"26","author":"Gao","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"R3-20251201","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/leu.2016.321","article-title":"Tracking T-cell immune reconstitution after TCR\u03b1\u03b2\/CD19-depleted hematopoietic cells transplantation in children.","volume":"31","author":"Zvyagin","year":"2017","journal-title":"Leukemia"},{"key":"R4-20251201","doi-asserted-by":"crossref","first-page":"e2400544","DOI":"10.1002\/advs.202400544","article-title":"Distinct immune homeostasis remodeling patterns after HLA-matched and haploidentical transplantation.","volume":"11","author":"Guo","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"R5-20251201","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41375-019-0654-y","article-title":"Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation.","volume":"34","author":"Buhler","year":"2020","journal-title":"Leukemia"},{"issue":"8","key":"R6-20251201","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1111\/ajt.13241","article-title":"Donor CD4 T cell diversity determines virus reactivation in patients after HLA-matched allogeneic stem cell transplantation.","volume":"15","author":"Ritter","year":"2015","journal-title":"Am J Transplant"},{"issue":"6712","key":"R7-20251201","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/25374","article-title":"Changes in thymic function with age and during the treatment of HIV infection.","volume":"396","author":"Douek","year":"1998","journal-title":"Nature"},{"issue":"9218","key":"R8-20251201","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0140-6736(00)02293-5","article-title":"Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution.","volume":"355","author":"Douek","year":"2000","journal-title":"Lancet"},{"key":"R10-20251201","doi-asserted-by":"crossref","first-page":"732826","DOI":"10.3389\/fimmu.2021.732826","article-title":"CMV infection and CMV-specific immune reconstitution following haploidentical stem cell transplantation: an update.","volume":"12","author":"Luo","year":"2021","journal-title":"Front Immunol"},{"key":"R11-20251201","doi-asserted-by":"crossref","first-page":"987220","DOI":"10.3389\/fped.2022.987220","article-title":"T-cell depleted haploidentical hematopoietic cell transplantation for pediatric malignancy.","volume":"10","author":"Takahashi","year":"2022","journal-title":"Front Pediatr"},{"issue":"15","key":"R12-20251201","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1182\/blood-2014-09-599423","article-title":"\u03b3\u03b4 T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-\u03b1\u03b2+\/CD19+ lymphocytes.","volume":"125","author":"Airoldi","year":"2015","journal-title":"Blood"},{"issue":"5","key":"R13-20251201","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after \u03b1\u03b2 T-cell and B-cell depletion.","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"issue":"1","key":"R14-20251201","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/bloodadvances.2021005628","article-title":"TCR\u03b1\u03b2\/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders.","volume":"6","author":"Merli","year":"2022","journal-title":"Blood Adv"},{"issue":"24","key":"R15-20251201","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1182\/blood-2018-07-861575","article-title":"Unrelated donor vs HLA-haploidentical \u03b1\/\u03b2 T-cell- and B-cell-depleted HSCT in children with acute leukemia.","volume":"132","author":"Bertaina","year":"2018","journal-title":"Blood"},{"issue":"3","key":"R16-20251201","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/blood.2023021336","article-title":"TCR\u03b1\u03b2\/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis.","volume":"143","author":"Merli","year":"2024","journal-title":"Blood"},{"issue":"7","key":"R17-20251201","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1172\/JCI81229","article-title":"Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.","volume":"125","author":"Bleakley","year":"2015","journal-title":"J Clin Invest"},{"issue":"11","key":"R18-20251201","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1200\/JCO.21.01755","article-title":"Naive T-cell depletion to prevent chronic graft-versus-host disease.","volume":"40","author":"Bleakley","year":"2022","journal-title":"J Clin Oncol"},{"issue":"Supplement 1","key":"R19-20251201","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1182\/blood-2022-164468","article-title":"Rapid immune reconstitution and elevated regulatory T cell frequencies in patients treated with orca-T.","volume":"140","author":"Meyer","year":"2022","journal-title":"Blood"},{"issue":"Supplement 1","key":"R20-20251201","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1182\/blood-2022-165654","article-title":"Precision-engineered cell therapy orca-T demonstrates high relapse-free survival at 1 year while reducing graft-versus-host disease and toxicity.","volume":"140","author":"Oliai","year":"2022","journal-title":"Blood"},{"issue":"5","key":"R21-20251201","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41409-023-01911-x","article-title":"HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia.","volume":"58","author":"Massei","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"R22-20251201","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"R23-20251201","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bmt.1705445","article-title":"Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies.","volume":"38","author":"Huang","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"18","key":"R24-20251201","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1182\/blood-2014-11-608406","article-title":"Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation.","volume":"125","author":"Roberto","year":"2015","journal-title":"Blood"},{"issue":"211","key":"R25-20251201","doi-asserted-by":"crossref","first-page":"211ra157","DOI":"10.1126\/scitranslmed.3006960","article-title":"Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide.","volume":"5","author":"Kanakry","year":"2013","journal-title":"Sci Transl Med"},{"issue":"2","key":"R26-20251201","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s10875-011-9630-7","article-title":"Immune reconstitution following unmanipulated HLA-mismatched\/haploidentical transplantation compared with HLA-identical sibling transplantation.","volume":"32","author":"Chang","year":"2012","journal-title":"J Clin Immunol"},{"issue":"10","key":"R27-20251201","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00277-015-2423-y","article-title":"Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings.","volume":"94","author":"Tischer","year":"2015","journal-title":"Ann Hematol"},{"issue":"8","key":"R28-20251201","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/bloodadvances.2017014464","article-title":"Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.","volume":"2","author":"Bejanyan","year":"2018","journal-title":"Blood Adv"},{"key":"R29-20251201","doi-asserted-by":"crossref","first-page":"893545","DOI":"10.3389\/fimmu.2022.893545","article-title":"Naive T cells in graft versus host disease and graft versus leukemia: innocent or guilty?","volume":"13","author":"Dekker","year":"2022","journal-title":"Front Immunol"},{"key":"R30-20251201","doi-asserted-by":"crossref","first-page":"1084901","DOI":"10.3389\/fimmu.2023.1084901","article-title":"Dynamic comparison of early immune reactions and immune cell reconstitution after umbilical cord blood transplantation and peripheral blood stem cell transplantation.","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Immunol"},{"key":"R31-20251201","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.imlet.2017.11.011","article-title":"Cell intrinsic characteristics of human cord blood naive CD4T cells.","volume":"193","author":"Jacks","year":"2018","journal-title":"Immunol Lett"},{"issue":"6011","key":"R32-20251201","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1126\/science.1196509","article-title":"Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans.","volume":"330","author":"Mold","year":"2010","journal-title":"Science"},{"issue":"3","key":"R33-20251201","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcyt.2020.01.005","article-title":"Rapid reconstitution of regulatory T-cell subsets is associated with reduced rates of acute graft-versus-host disease and absence of viremia after cord blood transplantation in children with reduced-intensity conditioning using alemtuzumab.","volume":"22","author":"Chen","year":"2020","journal-title":"Cytotherapy"},{"key":"R34-20251201","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3389\/fimmu.2020.00611","article-title":"Human regulatory T cells from umbilical cord blood display increased repertoire diversity and lineage stability relative to adult peripheral blood.","volume":"11","author":"Motwani","year":"2020","journal-title":"Front Immunol"},{"issue":"10","key":"R35-20251201","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/CM9.0000000000002807","article-title":"Reconstitution of double-negative T cells after cord blood transplantation and its predictive value for acute graft-versus-host disease.","volume":"137","author":"Pan","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"R36-20251201","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fimmu.2020.00191","article-title":"Key aspects of the immunobiology of haploidentical hematopoietic cell transplantation.","volume":"11","author":"Baumeister","year":"2020","journal-title":"Front Immunol"},{"key":"R37-20251201","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2025.288464","article-title":"MHC disparity hampers thymus-dependent T-cell recovery post-hematopoietic transplantation through dysregulation of TGF-\u03b21 and LRP6 pathways.","author":"Wu","year":"2025","journal-title":"Haematologica"},{"issue":"1","key":"R38-20251201","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41409-022-01842-z","article-title":"Impact of HLA-B leader matching on clinical outcomes after haploidentical transplantation using antithymocyte globulin-based conditioning.","volume":"58","author":"Wang","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"R39-20251201","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/cei.12187","article-title":"Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells.","volume":"174","author":"Merino","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"R40-20251201","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all.","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood"},{"issue":"11","key":"R41-20251201","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.ymthe.2018.09.008","article-title":"Low-dose radiation conditioning enables CAR T cells to mitigate antigen escape.","volume":"26","author":"DeSelm","year":"2018","journal-title":"Mol Ther"},{"issue":"4","key":"R42-20251201","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jcyt.2024.01.004","article-title":"Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patients.","volume":"26","author":"Lakkaraja","year":"2024","journal-title":"Cytotherapy"},{"issue":"3","key":"R43-20251201","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1182\/bloodadvances.2021005584","article-title":"Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation.","volume":"6","author":"Lakkaraja","year":"2022","journal-title":"Blood Adv"},{"issue":"8","key":"R44-20251201","doi-asserted-by":"crossref","first-page":"810.e1","DOI":"10.1016\/j.jtct.2024.05.015","article-title":"Model-based antithymocyte globulin in \u03b1\u03b2haplo-hematopoietic stem cell transplantation facilitates engraftment, expedites T cell recovery, and mitigates the risk of acute graft-versus-host disease.","volume":"30","author":"Barbarito","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"R45-20251201","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbmt.2008.05.023","article-title":"Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.","volume":"14","author":"Ayuk","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"R46-20251201","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41409-020-0792-x","article-title":"Rabbit ATG\/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel.","volume":"55","author":"Bonifazi","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"R47-20251201","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/bjh.16706","article-title":"CD52-negative T cells predict acute graft-versus-host disease after an alemtuzumab-based conditioning regimen.","volume":"191","author":"Woelfinger","year":"2020","journal-title":"Br J Haematol"},{"issue":"21","key":"R48-20251201","doi-asserted-by":"crossref","first-page":"e2200978","DOI":"10.1002\/advs.202200978","article-title":"Multiomics analysis identifies SOCS1 as restraining T cell activation and preventing graft-versus-host disease.","volume":"9","author":"Guo","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"R49-20251201","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood-2001-12-0291","article-title":"Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells.","volume":"100","author":"Rutella","year":"2002","journal-title":"Blood"},{"issue":"1","key":"R50-20251201","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41392-025-02183-1","article-title":"A donor PD-1(+)CD8(+) T(SCM)-like regulatory subset mobilized by G-CSF alleviates recipient acute graft-versus-host-disease.","volume":"10","author":"Liu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"R51-20251201","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molimm.2015.12.006","article-title":"Mechanisms for T cell tolerance induced with granulocyte colony-stimulating factor.","volume":"70","author":"Yang","year":"2016","journal-title":"Mol Immunol"},{"issue":"24","key":"R52-20251201","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1182\/blood.2023023697","article-title":"Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT.","volume":"143","author":"Sanz","year":"2024","journal-title":"Blood"},{"issue":"8","key":"R53-20251201","doi-asserted-by":"crossref","first-page":"e13671","DOI":"10.1111\/acel.13671","article-title":"Age-related thymic involution: mechanisms and functional impact.","volume":"21","author":"Liang","year":"2022","journal-title":"Aging Cell"},{"issue":"3","key":"R54-20251201","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/TP.0000000000004715","article-title":"The impact of T-cell aging on alloimmunity and inflammaging.","volume":"108","author":"Iske","year":"2024","journal-title":"Transplantation"},{"issue":"6","key":"R55-20251201","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s40620-016-0354-x","article-title":"Profiling risk for acute rejection in kidney transplantation: recipient age is a robust risk factor.","volume":"30","author":"Rana","year":"2017","journal-title":"J Nephrol"},{"issue":"2","key":"R56-20251201","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/TP.0b013e3182590d8f","article-title":"In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function.","volume":"94","author":"Miroux","year":"2012","journal-title":"Transplantation"},{"key":"R57-20251201","doi-asserted-by":"crossref","first-page":"115116","DOI":"10.1016\/j.bcp.2022.115116","article-title":"Insights gained from single-cell analysis of immune cells on cyclosporine A treatment in autoimmune uveitis.","volume":"202","author":"Duan","year":"2022","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"R58-20251201","doi-asserted-by":"crossref","first-page":"e000208","DOI":"10.1136\/jitc-2019-000208","article-title":"Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting V\u03b42+ T cells activities after hematopoietic transplantation for blood malignancies.","volume":"8","author":"Liu","year":"2020","journal-title":"J ImmunoTher Cancer"},{"issue":"18","key":"R60-20251201","doi-asserted-by":"crossref","first-page":"9973","DOI":"10.3390\/ijms22189973","article-title":"Functional changes of T-cell subsets with age and CMV infection.","volume":"22","author":"Hassouneh","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R61-20251201","doi-asserted-by":"crossref","first-page":"1027593","DOI":"10.3389\/fimmu.2022.1027593","article-title":"Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: impact of CMV infection and leukemia relapse.","volume":"13","author":"Luo","year":"2022","journal-title":"Front Immunol"},{"key":"R62-20251201","doi-asserted-by":"crossref","first-page":"1464096","DOI":"10.3389\/fimmu.2025.1464096","article-title":"Immune reconstitution of human cytomegalovirus-specific T lymphocytes after allogeneic hematopoietic stem cell transplantation and their predictive role in reactivation.","volume":"16","author":"Zhao","year":"2025","journal-title":"Front Immunol"},{"issue":"16","key":"R63-20251201","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1182\/bloodadvances.2019001032","article-title":"Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD.","volume":"4","author":"Latis","year":"2020","journal-title":"Blood Adv"},{"issue":"21","key":"R64-20251201","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1182\/blood-2016-07-726547","article-title":"Systems analysis uncovers inflammatory Th\/Tc17-driven modules during acute GVHD in monkey and human T cells.","volume":"128","author":"Furlan","year":"2016","journal-title":"Blood"},{"issue":"10","key":"R65-20251201","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1182\/blood-2013-02-482539","article-title":"Multiparameter single-cell profiling of human CD4+FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease.","volume":"122","author":"Dong","year":"2013","journal-title":"Blood"},{"key":"R66-20251201","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.imlet.2023.07.008","article-title":"Disturbance in the reconstitution of distinct T-cell subsets and the incidence of GvHD following allo-HSCT in pediatric patients with non-malignant hematological disorders.","volume":"261","author":"Bayegi","year":"2023","journal-title":"Immunol Lett"},{"issue":"12","key":"R67-20251201","doi-asserted-by":"crossref","first-page":"eadf0567","DOI":"10.1126\/sciadv.adf0567","article-title":"Inflammatory CD4\/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology.","volume":"9","author":"Hess","year":"2023","journal-title":"Sci Adv"},{"issue":"37","key":"R68-20251201","doi-asserted-by":"crossref","first-page":"eadw1702","DOI":"10.1126\/sciadv.adw1702","article-title":"CD8+ HLA-DR+ CD27+ T cells define a population of naturally occurring regulatory precursors in humans.","volume":"11","author":"Guo","year":"2025","journal-title":"Sci Adv"},{"key":"R69-20251201","doi-asserted-by":"crossref","first-page":"1433091","DOI":"10.3389\/fimmu.2024.1433091","article-title":"Monocytes as an early risk factor for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.","volume":"15","author":"Sun","year":"2024","journal-title":"Front Immunol"},{"issue":"81","key":"R70-20251201","doi-asserted-by":"crossref","first-page":"eabn6429","DOI":"10.1126\/sciimmunol.abn6429","article-title":"Single-cell dissection of human hematopoietic reconstitution after allogeneic hematopoietic stem cell transplantation.","volume":"8","author":"Huo","year":"2023","journal-title":"Sci Immunol"},{"key":"R71-20251201","doi-asserted-by":"crossref","first-page":"778996","DOI":"10.3389\/fimmu.2021.778996","article-title":"Donor T-cell repertoire profiling in recipient lymphoid and parenchyma organs reveals GVHD pathogenesis at clonal levels after bone marrow transplantation in mice.","volume":"12","author":"Wu","year":"2021","journal-title":"Front Immunol"},{"key":"R72-20251201","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ebiom.2019.02.001","article-title":"Co-activation of macrophages and T cells contribute to chronic GVHD in human IL-6 transgenic humanised mouse model.","volume":"41","author":"Ono","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"R73-20251201","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/blood.2020005770","article-title":"Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI.","volume":"137","author":"Assmann","year":"2021","journal-title":"Blood"},{"issue":"5","key":"R74-20251201","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1182\/blood.2020005170","article-title":"Retinoic acid-responsive CD8 effector T cells are selectively increased in IL-23-rich tissue in gastrointestinal GVHD.","volume":"137","author":"Ball","year":"2021","journal-title":"Blood"},{"issue":"24","key":"R75-20251201","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa1808777","article-title":"Immune escape of relapsed AML cells after allogeneic transplantation.","volume":"379","author":"Christopher","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"R76-20251201","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41591-019-0400-z","article-title":"Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation.","volume":"25","author":"Toffalori","year":"2019","journal-title":"Nat Med"},{"issue":"11","key":"R77-20251201","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood.2022015522","article-title":"Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse.","volume":"140","author":"Gournay","year":"2022","journal-title":"Blood"},{"issue":"13","key":"R78-20251201","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood.2023021815","article-title":"The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature.","volume":"143","author":"Mathioudaki","year":"2024","journal-title":"Blood"},{"issue":"1","key":"R79-20251201","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/s41467-019-08871-1","article-title":"Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT.","volume":"10","author":"Noviello","year":"2019","journal-title":"Nat Commun"},{"issue":"21","key":"R80-20251201","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1182\/bloodadvances.2020004073","article-title":"Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI.","volume":"5","author":"Schultze-Florey","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"R81-20251201","first-page":"17","article-title":"Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology.","volume":"45","author":"Glasson","year":"2023","journal-title":"Semin Immunopathol"},{"issue":"4","key":"R82-20251201","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/cac2.12023","article-title":"Overview of multiplex immunohistochemistry\/immunofluorescence techniques in the era of cancer immunotherapy.","volume":"40","author":"Tan","year":"2020","journal-title":"Cancer Commun (Lond)"},{"issue":"2","key":"R83-20251201","doi-asserted-by":"crossref","first-page":"108947","DOI":"10.1016\/j.isci.2024.108947","article-title":"A machine learning model identifies M3-like subtype in AML based on PML\/RAR\u03b1 targets.","volume":"27","author":"Shao","year":"2024","journal-title":"iScience"}],"container-title":["Blood Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BS9.0000000000000261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T21:00:19Z","timestamp":1764622819000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BS9.0000000000000261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":81,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/bs9.0000000000000261","relation":{},"ISSN":["2543-6368"],"issn-type":[{"value":"2543-6368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}